Aim Increased levels of acute phase proteins, e.g. fibrinogen, are related to a poor outcome in unstable coronary artery disease, but the cause of inflammation is unknown. We therefore investigated the prevalence of persistent Chlamydia pneumoniae infection, and its relationship to inflammation in this condition.
Introduction
There is increasing evidence of an inflammatory component in the pathophysiology of coronary artery disease [1] . T-lymphocytes and monocytes in the atheroma might influence the atherosclerotic process [2] . In the majority of acute coronary events, a plaque-fissure with a superimposed thrombus plays a pivotal role [3, 4] . Activated monocytes could facilitate plaque rupture by release of metalloproteinases [5] , and could also activate the coagulation system. Tissue factor exposed to plasma factor VII triggers the extrinsic coagulation cascade. Since bacterial lipopolysacharides, as well as C-reactive protein, induce surface tissue factor expression on monocytes [6] , chronic infections might augment thrombus formation after a plaque rupture. Furthermore, fibrinogen is an acute phase protein. Increased levels of fibrinogen facilitates platelet aggregation [7] and thrombus formation [8] ; this could be a second link between chronic infections and thrombotic conditions. An increased fibrinogen level is a well-known risk factor in long-term studies of apparently healthy individuals [9] , as well as in those with stable coronary artery disease [10] . Increased fibrinogen [11] , and to some extent C-reactive protein [12] concentrations have recently been associated with a worsened early outcome in unstable coronary artery disease. However, the identity of the antigens inducing the inflammatory response in coronary artery disease is unknown.
Chlamydia pneumoniae, an obligate intracellular parasite and a common cause of acute respiratory infection [13, 14] , has a tendency to cause persistent infection, which is often reflected by increased titres of IgA antibodies [15] . Increased C. pneumoniae antibody titres have not only been described in stable coronary artery disease and acute myocardial infarction [16] , but have also been ascribed prognostic significance in men with hyperlipidaemia [15] . The presence of C. pneumoniae in atherosclerotic plaques has been demonstrated by immunohistological [17] [18] [19] and PCR methods [18, 19] , and by electron microscopy [18, 20] and the bacterium has been isolated in cell culture from coronary artery tissue [20] ; but the pathophysiological significance is unclear. We therefore investigated the prevalence of persistent C. pneumoniae infections as well as the relationship of infection to other risk factors in unstable coronary artery disease, i.e. unstable angina and non-Q wave myocardial infarction.
Methods

Patient population
This investigation is a substudy of the FRISC trial, a randomized, multi-centre (23 hospitals), placebocontrolled study evaluating the effects of low molecular weight heparin (lmwh) in unstable coronary artery disease. A complete description of the FRISC study design, exclusion criteria and results has recently been published [21] . Men aged >40 years and post-menopausal females were enrolled from October 1992 to April 1994. Inclusion criteria were: recent onset (2 months) or accentuated angina pectoris, with the latest episode of chest-pain within 72 h; or chest pain at rest with suspicion of acute myocardial infarction. ECG criteria to be fulfilled were d0·1 mV ST-depression and/or T-wave inversion in two contiguous leads. Individuals with increased risk for bleeding (e.g. previous gastrointestinal bleeding or recent surgery), indication for thrombolysis (e.g. ST elevation or bundle branch block), fever d39 C, liver or renal insufficiency, previously planned coronary intervention or other serious diseases were excluded. After giving informed consent, the patients were randomized to placebo-controlled dalteparin sodium (lmwh) 120 IU . kg 1 body weight subcutaneously twice daily for 5-8 days, followed by 7500 IU in a fixed dose, subcutaneously once daily for the following 35-45 days. All patients received aspirin and beta-blockers if not contraindicated, and calcium blockers and mononitrates as needed. After 5-8 days of hospital treatment the patients were followed-up at outpatient visits after 6 weeks and 6 months. Coronary angiography and, if appropriate, revascularization was recommended for refractory or incapacitating angina despite optimal medical treatment or when patients demonstrated signs of severe ischaemia during exercise tests. The diagnosis of myocardial infarction at inclusion was done retrospectively using local enzymatic criteria. All primary end-points during the follow-up period were evaluated by an independent end-point committee. Acute myocardial infarction was defined according to the WHO criteria [22] . Two of the following criteria had to be fulfilled: (1) severe ischaemic chest pain of at least 20 min duration, (2) a diagnostic ECG, or (3) an increase in cardiac enzymes above the upper reference limit at the local hospital in at least two consecutive samples. The investigation was approved by the local ethical committees.
Blood samples
Venous EDTA blood samples were obtained at inclusion, after 12, 24 and 48 h and after 5 and 40-50 days, from 965 consecutive individuals at 15 participating hospitals. Plasma was stored, after centrifugation for 10 min at 2000 g, at 70 C in aliquots until analysed. In a case-control sub-study, all patients in the blood sample programme with an event (death or a subsequent myocardial infarction) during the 6-month follow-up period were matched by dalteparin/placebo treatment, age, gender and including centre, to a control patient without any event during the same period. Samples from complete case-control pairs were available from 256 individuals. Biochemical analyses of C. pneumoniae IgM, IgG and IgA antibodies were performed using the microimmunofluoresence (MIF) technique [23] . The sera were investigated for the presence of specific IgG, IgM and IgA antibodies using eggcultured elementary bodies from C. pneumoniae (IOL-207) as antigens (I. O. International Ltd). Sera with IgM or IgA antibodies were first absorbed with GullSorb (Gull Laboratories Inc, U.S.A.) to remove IgG antibodies prior to IgM and IgA antibody analysis. Serum dilutions were incubated overnight (16-20 h ) at 4 C with the antigen. Incubation with FITC-labelled second antibody (DAKOPATTS, Denmark) was done at 37 C for 30 min. All tests were read by the same investigator. Identification of specific C. pneumoniae IgA antibodies at a dilution of >1:64 was considered a sign of persistent infection, according to previous reports of findings among hyperlipidaemic men [15] and in cases with respiratory tract infections [23] . In a reference material of 190 randomly selected persons 70 years of age in 1992, 19% (36/190) had specific C. pneumoniae IgA antibodies in a titre of d64 (Steen B, Gause-Nilsson I, Gnarpe J, Gnarpe H: manuscript in preparation). All antibody titres were presented as reciprocal titres. Fibrinogen was analysed by rate nephelometry on a Beckman Array protein system (Beckman Instruments Inc, Brae, CA, U.S.A.). The assay was performed according to the recommendations of the manufacturer, except that goat anti-human fibrinogen (Atlantic Antibodies, Stillwater; MN, U.S.A.) was used. The assay was calibrated against a human plasma standard (Behring, Germany). C-reactive protein was analysed by turbidimetry on a Hitachi 717 (Boehringer-Mannheim, Mannheim, Germany) with sheep antibodies to C-reactive protein from Orion diagnostica (Espoo, Finland). Troponin T was measured using a kit from Boehringer Mannheim, Germany (Enzymun-Test), using a lower detection level of 0·04 g . l 1 . The upper reference level in healthy blood donors is 0·06 g . l 1 [24] . Previous studies show that at levels d0·1 g . l 1 indicates myocardial damage [25] .
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Eur Heart J, Vol. 19, April 1998 C. pneumoniae IgA antibody levels were determined for all individuals from samples taken within 24 h of inclusion. C. pneumoniae IgM and IgG antibody levels were evaluated in the first 147 individuals in addition to specific IgA antibody levels. Specific IgA antibody levels were also determined 40-50 days after inclusion if venous blood samples were available (n=72). The fibrinogen and C-reactive protein levels were measured in samples obtained at inclusion, while the troponin T levels were determined at inclusion and after 12 and 24 h. The maximum troponin T value during the 24 h after inclusion was used as an indication of myocardial damage.
Statistics
Since continuous variables were not normally distributed in the Liliefors test, values are presented in medians with 25th and 75th percentiles. Furthermore, non-parametric methods were applied in calculations. Proportions were evaluated by Pearson's chi-square test. Mantel-Haenzels linear trend test was applied in calculations including variables with more than two categories. The Mann-Whitney U test was applied in comparing continuous variables as well as the geometric mean of antibody titres in groups. Multivariate logistic forward stepwise regression analysis was performed to evaluate the association between increased C. pneumoniae IgA antibody titres and other risk markers at inclusion. Variables with a P-value <0·1 in univariate analysis (age, smoking habits, and levels of fibrinogen, C-reactive protein and troponin T) were added to the model. A P-value <0·05 was defined as significant. A computer with SPSS system 6.1 (Statistical Package for the Social Sciences, 1994) was used for statistical analysis.
Results
A C. pneumoniae IgA antibody titre d64 was present in 36% (93/256) of the individuals with unstable coronary artery disease compared to 19% (36/190) in the reference population. However, there was no difference between 'cases and controls' among the patients, as C. pneumoniae IgA antibodies d64 were present in 34% of the event group (death or a myocardial infarction during the 6 months follow-up period), compared to 39% of the event-free group; P=0·36. As a consequence of this finding, the two groups were merged into one cohort in the remaining analyses. The distribution of C. pneumoniae IgA antibodies in the patient population is presented in Fig. 1 .
The baseline characteristics in the patient population are presented in Table 1 . Patients with a C. pneumoniae IgA antibody titre d64 were more often previous or current smokers, had significantly increased fibrinogen and C-reactive protein levels, and had more frequently a maximum troponin T level of d0·1 g . l 1 ( Table 2 ). The distribution of C. pneumoniae IgA antibody titres in individuals with troponin T levels d0·1 g . l 1 vs <0·1 g . l 1 are presented in Fig. 2 . Increased titres of C. pneumoniae antibodies were more frequent in males than females, 41% vs 24%, P=0·01. The proportion of previous or current smokers was lower in females than in males (Table 2 ). In multiple, logistic regression analysis age, gender, smoking habits, fibrinogen levels and elevated troponin T were found to be independently associated with C. pneumoniae IgA antibody titres d64; C-reactive protein levels were not ( Table 3 ). The geometric titres of IgA antibodies were significantly increased in males compared to females, in older individuals, in smokers and in individuals with elevated troponin T values (Table 4 ). There was a tendency to increased geometric mean titres of IgA in individuals with increased fibrinogen compared to individuals with lower fibrinogen levels ( Table 4) . This difference was significant in males (218 vs 146; P=0·011), but not in females (25 vs 248; P=0·88) . No relationship between C-reactive protein levels and geometric mean titres of IgA antibodies was found ( Table 4 ). The geometric mean titres of IgA antibodies were greater in the individuals with unstable coronary artery disease compared to the reference population; 173 vs 45 (P<0·001).
The distribution of C. pneumoniae IgG antibody titres among the individuals with unstable coronary artery disease is presented in Fig. 3 . The geometric mean titre of IgG antibodies was higher in males compared to females; 499 vs 168 (P=0·002). Elevated C. pneumoniae Values are median (25th-75th percentiles) or number (%). MI=myocardial infarction. *At inclusion.
IgG antibody titre levels were not found in a larger proportion of individuals with a subsequent myocardial infarction or who died during the follow-up period and there was no correlation to the fibrinogen levels (data not presented). The geometric mean IgG antibody titres were greater in the patient population compared to the reference material; 389 vs 222 (P<0·001). This difference was significant in females, 169 vs 127 (P=0·032), but not in males, 499 vs 362 (P=0·070). Specific IgM-antibodies to C. pneumoniae were not detected in any of the 147 specimens examined. No individual had a significant, four-fold change or greater, in C. pneumoniae IgA antibody titre over the first 40 days follow-up.
Discussion
We have recently described a link between elevated fibrinogen levels and worsened short-term outcome in unstable coronary artery disease [26] . This prognostic association persisted even after compensating for risk factors commonly associated with increased fibrinogen concentrations, e.g. increasing age, diabetes mellitus and smoking. An association between elevated fibrinogen concentrations and increased C. pneumoniae antibody titres was found in men without any history of coronary heart disease in a previous report [27] . This finding suggested a possible link between chronic infection and coronary heart disease. As far as we are aware, the present investigation is the first to demonstrate an association between increased fibrinogen levels and persistent C. pneumoniae infection defined as specific IgA titres of >64, independent of age, gender and smoking habits, in individuals with coronary artery disease.
A plaque-fissure with a superimposed thrombus plays a pivotal role in acute coronary syndromes [28, 29] . However, plaque-fissures without subsequent thrombus formation have frequently been found at autopsy after non-cardiovascular death [30] . Chronic infection with C. pneumoniae may be associated with increased risk for both plaque rupture and a thrombotic tendency, and may thereby contribute to an increased risk for developing acute coronary artery disease.
Increased C-reactive proteins levels were associated with persistent C. pneumoniae infection in the present investigation. However, this association was not significant in calculations based on geometric mean titres of IgG antibodies or after compensating for the influence of other variables, i.e. age, smoking habits, fibrinogen and troponin T concentrations. This is in accordance with recently reported findings from a crosssectional population study of men aged 50-69 years [31] . We could confirm the previous findings, of an increased prevalence of elevated C. pneumoniae antibody titres in individuals with increased age [15] , in males [32] , in smokers [15] -all well-known risk factors for coronary artery disease. The association between increased risk of coronary artery disease and these risk factors might be influenced by their association with a persistent C. pneumoniae infection.
We used a C. pneumoniae IgA antibody titre of 64 or greater as a marker for persistent infection. The rationale for using this cut-off value is based on the previous finding of a prognostic value of C. pneumoniae infections in this subgroup [15] and on findings in a longitudinal study of healthy blood donors, where specific C. pneumoniae antibody titres of d64 were rare [32] . Despite the use of this fairly high cut-off limit, the prevalence of persistent C. pneumoniae infection was (10) 5 (7) ns 12 (23) 3 (18) ns 23 (14) 8 (9) ns Hypertension 81 (26) 48 ( (46) 20 (27) 39 (74) 14 (82) 90 (55) 34 (37) Previous smoker
44 (40) 36 (47) 9 (17) 2 (12) 53 (33) 38 (41) Current smoker
15 (14) 20 (27) 0·003* 5 (9) 1 (6) ns* 20 (12) 21 ( found to be as high as 36% in the present patient material. This markedly increased frequency of elevated C. pneumoniae IgA antibody titres in our material, compared to the findings in the reference population, raised the suspicion that persistent C. pneumoniae infection could be a risk factor of major importance in unstable coronary artery disease. As the reference population is a cross-sectional cohort it includes healthy individuals as well as patients, so that the differences in antibody titres compared to the patient material is not diminished. An adverse prognostic influence by increased C. pneumoniae IgA antibody titres has previously been reported in hyperlipidaemic men [15] . The present study could not confirm this finding. However, these two study populations were different. In the FRISC trial, subjects with an acute coronary syndrome were selected, thereby constituting a population with a more severe prognosis. Thus, it is possible that an ongoing C. pneumoniae infection might have had an influence on the development of the index event rather than on the short-term risk of a further event. Furthermore, despite the casecontrol design, the statistical power might have been insufficient to reveal the prognostic importance of increased C. pneumoniae antibody titres. An indication of this possibility is that an increased fibrinogen concentration was a strong prognostic marker in the total patient material, while not significant in this smaller sub-group. Furthermore, the association between increased C. pneumoniae antibody titres and troponin T, 
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an important prognostic marker in unstable coronary artery disease [33] , might indicate an association with an increased risk of an adverse outcome.
Finally, could the increased frequency of C. pneumoniae infection in acute coronary artery disease reflect a reactivation of a latent infection? This seems unlikely, as all but one individual had stable IgA antibody titres as a sign of persistent infection. The serum half life of IgA is 5-6 days [32] . We conclude that persistent C. pneumoniae infection is a common finding in individuals with unstable coronary artery disease and twice as frequent as in a reference population. The association between increased fibrinogen levels and persistent C. pneumoniae infection could be an important link between chronic infections and the athero-thrombotic diseases. 
